Patient Leaflet Updated 05-Oct-2022 | Bausch & Lomb U.K Limited
Lotemax 0.5% Eye Drops, Suspension
Lotemax 0.5% Eye Drops, Suspension
Loteprednol Etabonate
1. What Lotemax is and what it is used for
2. What you need to know before you use (Invented name)
3. How to use Lotemax)
4. Possible side effects
5. How to store Lotemax
6. Contents of the pack and other information
Lotemax is an eye drop suspension.
Lotemax is used to treat inflammation of the eye, after surgery.
Sometimes the eye may become inflamed (red and painful). Loteprednol etabonate is one of a group of medicines called corticosteroids. It acts by reducing inflammation and eases the symptoms. Because it is used in low doses directly where it is needed, its action is only at this place.
Tell your doctor if you already have glaucoma.
Contact your doctor if you experience blurred vision or other visual disturbances.
Tell your doctor if pain develops, or if redness, itching, or inflammation gets worse.
See your doctor if your symptoms do not get better within 2 days. He/she may want to re-evaluate your condition.
You should not use Lotemax longer than 10 days without having the pressure in your eye checked by your doctor.
Long-term use of Lotemax or other eye drops that contain steroids, may result in glaucoma or raised pressure in the eye, which can cause damage to the optic nerve, problems with vision, and cataracts.
Long-term use of Lotemax or other eye drops that contain steroids, may lower your ability to fight infections and may increase your chance of getting an eye infection including herpes simplex.
Using steroid eye drops like Lotemax may make viral diseases of the eye worse and last longer.
Contact lenses
Wearing contact lenses is not recommended after cataract surgery. If you normally wear contact lenses, your doctor will recommend you use glasses for a time following cataract surgery. This is to allow your eyes to recover from the procedure. Your doctor will advise you when you can use contact lenses again (see also “(Lotemax contains benzalkonium chloride”).
Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Especially, tell you doctor if you use:
Some medicines may increase the effects of Lotemax and your doctor may wish to monitor you carefully if you are taking these medicines (including some medicines for HIV: ritonavir, cobicistat).
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
It is possible that you may still receive Lotemax, but it is also possible that an alternative may be used.
Lotemax should not be used when breast-feeding.
Eye drops can cause your vision to be blurred. This usually passes quickly. Do not drive or use machines until your vision is clear.
This medicine contains 0.0152 mg benzalkonium chloride in each dosage unit (2 drops) which is equivalent to 0.20 mg/1 ml.
Benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses. You should remove contact lenses before using this medicine and put them back 15 minutes afterwards.
Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or disorders of the cornea (the clear layer at the front of the eye). If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor.
Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose for adults and elderly is one to two drops four times daily.
Treatment with Lotemax normally begins 24 hours after surgery and continues for two weeks.
Lotemax should not be used in children and adolescents until further data becomes available.
Tell your doctor or a pharmacist.
Do not take a double dose to make up for a forgotten dose.
Wait until the next dose and then continue as before.
Always use this medicine exactly as your doctor has told you. Do not stop using Lotemax without speaking to your doctor first.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any of the following symptoms: redness, itching or swelling of the membrane covering the white part of the eye and/or eyelid(s) or general symptoms such as difficulty breathing, difficulty swallowing, flushing or redness of the face and swelling of the face or tongue you should stop using this medicine and seek immediate medical advice. These could be the signs of severe allergic reaction.
The side effects listed below may also occur during treatment with this medicine:
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1,000 people):
Not known: frequency cannot be estimated from the available data:
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:
United Kingdom
or search for MHRA Yellow Card in the Google Play or Apple App Store.
Ireland
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store the container in an upright position.
Do not store above 25ºC. Do not freeze.
Do not use this medicine after the expiry date which is stated on the carton and bottle after expiry. The expiry date refers to the last day of that month.
Throw away any solution 28 days after opening.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.>
DO NOT USE IF PROTECTIVE SEAL IS BROKEN
Lotemax is a milky-white eye-drops suspension.
Lotemax is available in bottles containing 2.5 mL, 5 mL or 10 mL.
Not all pack sizes may be marketed.
IE:
UK:
This leaflet was last revised in: August 2022
Other sources of information
For any information about this medicine, please contact
Lotemax is a registered trademark of Bausch & Lomb Incorporated or its affiliates.
©Bausch & Lomb Incorporated
Bausch & Lomb House, 106 London Road, Kingston-upon-Thames, Surrey, KT2 6TN, UK
+44 (0)208 781 2900
Tel: +44 (0)208 781 2991 Fax: +44 (0)208 781 295